News of the Free: Invasive Fungal Infections after Anti-CD19 Chimeric Antigen Receptor-Modified T-Cell Therapy: State of the Evidence and Future Directions.

Saturday, January 1, 2022

Invasive Fungal Infections after Anti-CD19 Chimeric Antigen Receptor-Modified T-Cell Therapy: State of the Evidence and Future Directions.

http://europepmc.org/article/PMC/PMC7927024?fbclid=IwAR2a9cIkleAr0bAT3AAaB3uaYFbOXlo2yY1lfyIQ4LHuMJ7P4j4b4jwPHIo

No comments:

Subscribe to: Post Comments (Atom)